Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug crawled date : 2021 - 09 - 20 save search
Verrica Pharmaceuticals Receives Complete Response Letter from the FDA identifying deficiencies at a facility of a Contract Manufacturer for its New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
Published: 2021-09-20 (Crawled : 22:00) - biospace.com/
VRCA | $6.96 0.87% 0.72% 130K
|
Health Technology
|
| O: -1.15%
H: 3.08%
C: 0.0%
molluscum new drug treatment fda contract drug
OneLegacy Foundation Funded UCLA Clinical Trial Successfully Completes Kidney Transplant Without Lifetime of Immunosuppressive Drugs
Published: 2021-09-20 (Crawled : 18:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
trial drug kidney
Global Drug Delivery Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021
Published: 2021-09-20 (Crawled : 15:00) - prnewswire.com
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -1.16%
H: 0.0%
C: 0.0%
drug drug delivery liver
Onconova Therapeutics Announces Upcoming Presentation at the 3rd Annual RAS Targeted Drug Development Summit
Published: 2021-09-20 (Crawled : 13:15) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: -4.11%
H: 2.04%
C: -3.67%
presentation drug
Blade Therapeutics Announces Positive Data from Preclinical Drug-Drug Interaction Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis (IPF)
Published: 2021-09-20 (Crawled : 13:00) - biospace.com/
GLPG | News | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: -2.97%
H: 2.56%
C: 1.65%
fibrosis positive drug preclinical cudetaxestat pre-clinical
Marinus Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Ganaxolone in CDKL5 Deficiency Disorder
Published: 2021-09-20 (Crawled : 12:15) - biospace.com/
MRNS | $1.38 -2.13% -2.17% 2.6M
|
Health Technology
|
| O: 3.32%
H: 4.57%
C: -0.59%
new drug fda fda acceptance drug application
Rhythm Pharmaceuticals Completes Submission of Supplemental New Drug Application to U.S. Food and Drug Administration for IMCIVREE®
Published: 2021-09-20 (Crawled : 12:15) - biospace.com/
RYTM A | $37.975 -0.35% -0.36% 620K
|
Health Technology
|
| O: 2.11%
H: 1.03%
C: -3.44%
new drug food drug submission imcivree application
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma
Published: 2021-09-20 (Crawled : 12:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.18%
H: 1.22%
C: -0.23%
food treatment antibody drug nivolumab
Aerie Pharmaceuticals Announces Appointment of Erik Pacyniak, Ph.D., D.A.B.T., as Director, Toxicology and Drug Disposition
Published: 2021-09-20 (Crawled : 12:00) - biospace.com/
AERI | $15.25 0.0%
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
drug
Matinas BioPharma Announces Accomplished Biotechnology Executive and Drug Developer Kathryn Penkus Corzo as Nominee to the Board of Directors
Published: 2021-09-20 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.35%
H: 0.0%
C: 0.0%
MTNB | $0.1877 -1.21% 0.0% 330K
|
Health Technology
|
| O: -4.27%
H: 1.79%
C: -1.79%
biopharma biotech drug technology iot
Rhythm Pharmaceuticals Completes Submission of Supplemental New Drug Application to U.S. Food and Drug Administration for IMCIVREE® (setmelanotide) for the treatment of obesity and control of hunger in Bardet-Biedl and Alström Syndromes
Published: 2021-09-20 (Crawled : 12:00) - globenewswire.com
RYTM A | $37.975 -0.35% -0.36% 620K
|
Health Technology
|
| O: 2.11%
H: 1.03%
C: -3.44%
new drug food treatment obesity drug submission setmelanotide imcivree syndros
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.